Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:258-263
Published online before print November 4, 2004, doi: 10.1161/01.ATV.0000149675.83552.83
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/1/258    most recent
01.ATV.0000149675.83552.83v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merten, M.
Right arrow Articles by Thiagarajan, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merten, M.
Right arrow Articles by Thiagarajan, P.
Related Collections
Right arrow Secretion
Right arrow Signal transduction
Right arrow Platelet function inhibitors
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:258.)
© 2005 American Heart Association, Inc.


Thrombosis

Sulfatides Activate Platelets Through P-Selectin and Enhance Platelet and Platelet–Leukocyte Aggregation

Michael Merten; Christian Beythien; Kai Gutensohn; Peter Kühnl; Thomas Meinertz; Perumal Thiagarajan

From the Division of Cardiology (M.M., T.M.) and the Department of Internal Medicine and Department of Transfusion Medicine (K.G., P.K.), University Hospital Hamburg-Eppendorf, Hamburg, Germany; the Division of Cardiology (C.B.), Department of Internal Medicine, University Hospital Rostock, Germany; and the Department of Pathology and Medicine (P.T.), Baylor College of Medicine, Houston, Tex.

Correspondence to Dr Michael Merten, Division of Cardiology, Department of Internal Medicine, University Hospital Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany. E-mail michael_merten{at}yahoo.com

Objective— Sulfatides are sulfated glycosphingolipids present on the surface of a variety of cells; however, their exact physiological function is not known. Recently, we have shown that the inhibition of sulfatide–P-selectin interactions leads to disaggregation of platelet aggregates.

Methods and Results— In this study, we show that sulfatides activated platelets as they increased activation of GPIIb/IIIa (PAC-1 epitope) and expression of P-selectin on the platelet surface. Furthermore, sulfatides aggregated washed platelets in a dose-dependent manner and enhanced platelet aggregation in platelet-rich plasma. Previous activation of platelets was necessary for this effect. Monoclonal anti–P-selectin antibodies inhibited not only sulfatide-induced PAC-1 binding to platelets but also sulfatide-induced platelet aggregation, suggesting that sulfatides activate platelet GPIIb/IIIa via signaling through P-selectin. The proaggegatory effect of sulfatides was also observed in an ex vivo thrombosis model using whole blood and pulsatile flow at 37°C. In this model, sulfatides significantly enhanced platelet aggregation and the formation of platelet–leukocyte aggregates.

Conclusions— We show that sulfatide-P-selectin interactions lead to subsequent platelet activation and P-selectin expression, forming a positive feedback loop that can potentiate formation of stable platelet aggregates. In addition, sulfatides enhance the aggregation of platelet–leukocyte aggregates. These mechanisms may play a significant role in hemostasis and thrombosis.

Sulfatides, sulfated glycosphingolipids, activated platelets via P-selectin as determined by an increase in activation of platelet GPIIb/IIIa and P-selectin. Therefore, sulfatides provide a positive feedback loop that can potentiate platelet aggregation. Furthermore, sulfatides aggregated washed platelets in a dose-dependent manner. In an ex vivo thrombosis model, sulfatides enhanced platelet and platelet–leukocyte aggregation.


Key Words: sulfatides • P-selectin • platelet aggregation • platelet–leukocyte aggregation




This article has been cited by other articles:


Home page
BloodHome page
E. Pluskota, N. M. Woody, D. Szpak, C. M. Ballantyne, D. A. Soloviev, D. I. Simon, and E. F. Plow
Expression, activation, and function of integrin {alpha}M{beta}2 (Mac-1) on neutrophil-derived microparticles
Blood, September 15, 2008; 112(6): 2327 - 2335.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. V. Popovic, R. Sandhoff, T. P. Sijmonsma, S. Kaden, R. Jennemann, E. Kiss, E. Tone, F. Autschbach, N. Platt, E. Malle, et al.
Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity
J. Immunol., November 15, 2007; 179(10): 6770 - 6782.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. Garcia, N. Callewaert, and L. Borsig
P-selectin mediates metastatic progression through binding to sulfatides on tumor cells
Glycobiology, February 1, 2007; 17(2): 185 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Atkinson, H. Zhu, F. Qiao, J. C. Varela, J. Yu, H. Song, M. S. Kindy, and S. Tomlinson
Complement-Dependent P-Selectin Expression and Injury following Ischemic Stroke
J. Immunol., November 15, 2006; 177(10): 7266 - 7274.
[Abstract] [Full Text] [PDF]